AAAAAA
Results:
1-11
|
Results: 11
Authors:
Morimoto, S
Tokano, Y
Kaneko, H
Nozawa, K
Amano, H
Hashimoto, H
Citation: S. Morimoto et al., The increased interleukin-13 in patients with systemic lupus erythematosus: Relations to other Th1-, Th2-related cytokines and clinical findings, AUTOIMMUN, 34(1), 2001, pp. 19-25
Authors:
Suzuki, J
Morimoto, S
Amano, H
Tokano, Y
Takasaki, Y
Hashimoto, H
Citation: J. Suzuki et al., Serum levels of interleukin 15 in patients with rheumatic diseases, J RHEUMATOL, 28(11), 2001, pp. 2389-2391
Authors:
Taniguchi, J
Tokano, Y
Miyamoto, I
Komuro, M
Hiroshima, H
Kobayashi, K
Miyazaki, T
Ohyi, H
Citation: J. Taniguchi et al., Preparation of diamond mold using electron beam lithography for application to nanoimprint lithography, JPN J A P 1, 39(12B), 2000, pp. 7070-7074
Authors:
Komuro, M
Taniguchi, J
Inoue, S
Kimura, N
Tokano, Y
Hiroshima, H
Matsui, S
Citation: M. Komuro et al., Imprint characteristics by photo-induced solidification of liquid polymer, JPN J A P 1, 39(12B), 2000, pp. 7075-7079
Authors:
Amano, H
Morimoto, S
Kaneko, H
Tokano, Y
Takasaki, Y
Hashimoto, H
Citation: H. Amano et al., Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers, LUPUS, 9(1), 2000, pp. 26-32
Authors:
Ito, H
Matsushita, S
Tokano, Y
Nishimura, H
Tanaka, Y
Fujisao, S
Mitsuya, H
Hashimoto, H
Nishimura, Y
Citation: H. Ito et al., Analysis of T cell responses to the beta(2)-glycoprotein I-derived peptidelibrary in patients with anti-beta(2)-glycoprotein I antibody-associated autoimmunity, HUMAN IMMUN, 61(4), 2000, pp. 366-377
Authors:
Morimoto, S
Kanno, Y
Tanaka, Y
Tokano, Y
Hashimoto, H
Jacquot, S
Morimoto, C
Schlossman, SF
Yagita, H
Okumura, K
Kobata, T
Citation: S. Morimoto et al., CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses, J IMMUNOL, 164(8), 2000, pp. 4097-4104
Authors:
Takasaki, Y
Abe, K
Tokano, Y
Hashimoto, H
Citation: Y. Takasaki et al., The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: Implication for immunotherapy, INTERN MED, 38(2), 1999, pp. 175-177
Authors:
Kaneko, H
Ogasawara, H
Naito, T
Akimoto, H
Lee, S
Hishikawa, T
Sekigawa, I
Tokano, Y
Takasaki, Y
Hirose, SI
Hashimoto, H
Citation: H. Kaneko et al., Circulating levels of beta-chemokines in systemic lupus erythematosus, J RHEUMATOL, 26(3), 1999, pp. 568-573
Authors:
Tokano, Y
Morimoto, S
Kaneko, H
Amano, H
Nozawa, K
Takasaki, Y
Hashimoto, H
Citation: Y. Tokano et al., Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th1-and Th2-derived cytokines, CLIN EXP IM, 116(1), 1999, pp. 169-173
Authors:
Lee, S
Kaneko, H
Sekigawa, I
Tokano, Y
Takasaki, Y
Hashimoto, H
Citation: S. Lee et al., Circulating interleukin-16 in systemic lupus erythematosus, BR J RHEUM, 37(12), 1998, pp. 1334-1337
Risultati:
1-11
|